Medicare Enrolled
Dr. Raymond Lance, M.D.
Urology Physician · Spokane, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lance from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lance?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lance
Dr. Raymond Lance is an urology physician in Spokane, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lance performed 3,360 Medicare services across 1,624 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lance received a total of $171,070 from 60 pharmaceutical and/or device companies across 524 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lance is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in WA
$171,070 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,360
Medicare services
Top 18% in WA for urology physician
1,624
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,140 | $18 | $33 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
484 | $65 | $167 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 193 | $136 | $380 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
136 | $3 | $33 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $98 | $243 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
127 | $187 | $513 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
118 | $8 | $21 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $124 | $348 |
| Injection, garamycin, gentamicin, up to 80 mg | 93 | $2 | $5 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
71 | $20 | $54 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
69 | $19 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $40 | $131 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
54 | $11 | $88 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
53 | $27 | $101 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
49 | $85 | $244 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
47 | $8 | $50 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
46 | $34 | $76 |
| Prostate needle biopsy with image guidance A procedure to remove small tissue samples from the prostate gland using a needle. Image guidance is used to help the doctor accurately locate the area for sampling. |
43 | $286 | $825 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
41 | $116 | $439 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
32 | $192 | $618 |
| PSA test (prostate cancer screening) | 32 | $18 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $75 | $243 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
26 | $64 | $126 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
24 | $25 | $48 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
19 | $74 | $350 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
18 | $638 | $1,700 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $262 | $492 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
15 | $59 | $128 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
15 | $937 | $3,570 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
15 | $66 | $250 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
14 | $264 | $1,500 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
13 | $340 | $915 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
13 | $18 | $45 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
12 | $98 | $450 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
11 | $82 | $182 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
47.6% medium
50.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$171,070
Total received (2018-2024)
Avg $24,439/year across 7 years
Top 2% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
524
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$144,497 (84.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,779 (10.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,795 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,249
2023
$15,903
2022
$31,390
2021
$12,561
2020
$32,234
2019
$48,562
2018
$23,171
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$4,528
Janssen Biotech, Inc.
$560
Ferring Pharmaceuticals Inc.
$412
Dendreon Pharmaceuticals LLC
$331
Sumitomo Pharma America, Inc.
$292
ACCORD HEALTHCARE, INC.
$256
Verity Pharmaceuticals Inc.
$218
ABBVIE INC.
$176
INTUITIVE SURGICAL, INC.
$94
Endo USA, Inc.
$45
Boston Scientific Corporation
$43
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
Tolmar, Inc.
$40
PFIZER INC.
$38
Blue Earth Diagnostics Limited
$31
180 Medical, Inc.
$29
Endo Pharmaceuticals Inc.
$23
PROGENICS PHARMACEUTICALS, INC.
$22
IMMUNITYBIO, INC.
$21
Cook Medical LLC
$18
Merck Sharp & Dohme LLC
$15
Olympus America Inc.
$15
Top 3 companies account for 75.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$98,463
Astellas Pharma US Inc
$32,208
Bayer HealthCare Pharmaceuticals Inc.
$24,236
Dendreon Pharmaceuticals LLC
$4,508
Bayer Healthcare Pharmaceuticals Inc.
$2,601
Janssen Scientific Affairs, LLC
$2,013
Myovant Sciences Inc.
$1,728
Sumitomo Pharma America, Inc.
$480
Ferring Pharmaceuticals Inc.
$412
ABBVIE INC.
$318
Myriad Genetic Laboratories, Inc.
$279
ACCORD HEALTHCARE, INC.
$256
Verity Pharmaceuticals Inc.
$253
Endo Pharmaceuticals Inc.
$223
Rochester Medical Corporation
$212
Analogic Corporation
$209
Intuitive Surgical, Inc.
$200
Boston Scientific Corporation
$187
PFIZER INC.
$164
Sun Pharmaceutical Industries Inc.
$155
NeoTract Inc.
$124
BOSTON SCIENTIFIC CORPORATION
$121
Palette Life Sciences, Inc.
$118
AbbVie, Inc.
$108
Blue Earth Diagnostics Limited
$105
INTUITIVE SURGICAL, INC.
$94
KARL STORZ Endoscopy-America
$90
Janssen Products, LP
$85
Olympus America Inc.
$80
Allergan, Inc.
$76
Progenics Pharmaceuticals, Inc.
$75
COLOPLAST CORP
$67
Novartis Pharmaceuticals Corporation
$66
TOLMAR Pharmaceuticals, Inc.
$60
AbbVie Inc.
$60
Tolmar, Inc.
$58
Astellas Pharma Global Development
$46
BAXTER HEALTHCARE
$45
Endo USA, Inc.
$45
Merck Sharp & Dohme LLC
$42
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
AstraZeneca Pharmaceuticals LP
$35
Alnylam Pharmaceuticals Inc.
$30
180 Medical, Inc.
$29
Baxter Healthcare
$23
PROGENICS PHARMACEUTICALS, INC.
$22
Coloplast Corp
$21
IMMUNITYBIO, INC.
$21
C. R. Bard, Inc. & Subsidiaries
$20
Axonics, Inc.
$19
Cook Medical LLC
$18
Ethicon US, LLC
$18
Amgen Inc.
$16
Wilmington Medical Supply, Inc.
$16
Antares Pharma, Inc.
$14
Allergan Inc.
$13
Ambu Inc.
$13
Medtronic USA, Inc.
$13
UroMed, Inc.
$11
Travere Therapeutics, Inc.
$8
Top 3 companies account for 90.6% of all-time payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · ADSTILADRIN · AFINITOR · AMS · ANKTIVA · AVEED · Axonics r-SNM System · Axumin · BALVERSA · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · CAMCEVI · COOK · Coloplast TFL Drive · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL - ONCOLOGY · GENTLECATH · GENTLECATH GLIDE · INLAY OPTIMA · INTERSTIM · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · OXLUMO · Odomzo · Olympus Cystoscopes · PLUVICTO · POSLUMA · PRECISETUMOR · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · REZUM · SOLTIVE · SUTENT · SpeediCath · Surgicel Powder · TISSEEL · Thiola · Titan · Trelstar · URETERO-RENO VIDEOSCOPE · UroLift · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · n.a. · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for urology physician in WA.
Geographic Context
Urology physicians within 10 mi
23
Per 100K population
4.2
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lance is a clinical cardiology specialist, with above-average Medicare volume (top 18% in WA), with speaking/promotional industry engagement in the top 2% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lance experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lance performed 1,140 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lance receive payments from pharmaceutical companies?
Yes. Dr. Lance received a total of $171,070 from 60 companies across 524 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lance's costs compare to other urology physicians in Spokane?
Dr. Lance's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lance) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Spokane
Browse urology physicians in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology